Vaccines

06 Apr 2007 BioMS Medicals's Pivotal Multiple Sclerosis Trial Receives Positive Interim Safety Analysis
05 Apr 2007 Regulatory approval to start pediatric clinical trials for Japanese Encephalitis (JE) Vaccine in Ind
05 Apr 2007 CytoGenix Announces Successful Testing of synDNA(TM) Vaccine for Avian Influenza Virus
04 Apr 2007 Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
04 Apr 2007 LigoCyte Pharmaceuticals Initiates U.S. Clinical Trial Of Norovirus Vaccine
04 Apr 2007 Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with Tovaxin(TM) for Multiple Sclerosis
03 Apr 2007 Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data Show
03 Apr 2007 FDA approves accelerated dosing schedule for GlaxoSmithKline's Twinrix(R)
03 Apr 2007 CSL Biotherapies Submits BLA to Introduce Flu Vaccine to U.S. Market
31 Mar 2007 GlaxoSmithKline files meningococcal conjugate vaccine
30 Mar 2007 Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
30 Mar 2007 Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
30 Mar 2007 Dendreon Announces FDA Advisory Committee Reviewed Provenge(R) for Hormone Refractory Prostate Cancer
30 Mar 2007 GlaxoSmithKline submits biologics license application to US Food and Drug Administration for Cervarix(R)
29 Mar 2007 Oxford BioMedica and Sanofi-Aventis Enter Global Licensing Agreement to Develop and Commercialise TroVax for Cancer
22 Mar 2007 Acambis PLC (ACAM) is First Company to Test a West Nile Virus Vaccine in Older Adults
21 Mar 2007 GenVec Signs Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases (NIAID) to Develop RSV Vaccines
16 Mar 2007 British doctors to start new phase III trial with Pharmexa's GV1001
15 Mar 2007 Novel tuberculosis vaccine shows promising immunogenicity and safety profile
15 Mar 2007 Prima Biomed Final Phase IIa Results for Ovarian Cancer Treatment Exceeded Expectations
15 Mar 2007 immatics granted orphan drug status for therapeutic cancer vaccine IMA901
14 Mar 2007 Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
13 Mar 2007 Preclinical Update – Debio-0512 Therapeutic Vaccine For The Treatment Of Chronic And Acute Inflammatory Conditions
10 Mar 2007 Curalogic has started clinical EU phase III trial with its ragweed product
09 Mar 2007 Diamyd Medical Announces Phase III Clinical Trials Plan For Diamyd(R) In Type 1 Diabetes

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top